PML in a patient treated with dimethyl fumarate from a compounding pharmacy

New England Journal of Medicine

Volumn 368, Issue 17, 2013, Pages 1658-1659

  Van Oosten, Bob W ^a   Killestein, Joep ^a   Barkhof, Frederik ^a   Polman, Chris H ^a   Wattjes, Mike P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ASCORBATE; FUMARIC ACID DIMETHYL ESTER; ICOSAPENTAENOIC ACID; MEFLOQUINE; METHYLPREDNISOLONE; MIRTAZAPINE; PSORINOVO; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HEMIPARESIS; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; WHITE MATTER LESION;

EID: 84876591025     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1215357     Document Type: Letter

References (5)

1. Reich K, Thaci D, Mrowietz U, Kamps A, Neureither M, Luger T. Efficacy and safety of fumaric acid esters in the long-term treatment of psoriasis - a retrospective study (FUTURE). J Dtsch Dermatol Ges 2009;7:603-11.
2. Yousry TA, Pelletier D, Cadavid D, et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 2012;72:779-87.
3. Ropper AH. The "poison chair" treatment for multiple sclerosis. N Engl J Med 2012;367:1149-50.
4. Ashrafian H, Czibik G, Bellahcene M, et al. Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab 2012;15:361-71.
5. Meissner M, Valesky EM, Kippenberger S, Kaufmann R. Dimethyl fumarate - only an anti-psoriatic medication? J Dtsch Dermatol Ges 2012;10:793-801.